Childen's Hospital Boston
International Visitorsdotted lineRequest Appointmentdotted lineDirections
 advanced search
About Us Find a Specialist Locations Careers Press Room Giving To
Clinical Services For Patients & Families For Health Professionals Research
My Child Has
or find by letter:  A-F  G-L  M-R  S-Z
Find a Specialist
 X
Printer Friendly

Andrew Li-Jen Kung, MD, PhD

 Previous | Next  | Return to Search Results

Departments/Divisions
Hematology/Oncology
Medicine
Transplantation

Specialties
bone marrow and stem cell transplantation
hematology/oncology
oncology

Services/Programs
Bone Marrow and Stem Cell Transplantation
Oncology

Clinical Title
Assistant in Medicine

Academic Appointment
Assistant Professor in Pediatrics, Harvard Medical School

Board Certification(s)
Pediatric Hematology/Oncology

 

Professional History
 
Medical/Dental School
Stanford University School of Medicine, Stanford, CA (1994)

Internship
Children's Hospital Boston, Boston, MA (07/94 to 06/95)

Residency
Pediatrics, Children's Hospital Boston, Boston, MA (07/95 to 06/96)

Fellowship
Children's Hospital Boston/Dana Farber Cancer Institute, Boston, MA (07/96 to 06/99)

Research Activities

  • Development of targeted therapies
    Cancer Cell 2005, 7: 129
    Clin Cancer Res 2006, 12: 6765
    PLOS Med 2007, 4: e122
    J Clin Invest 2008, 188: 3109
     
  • Role of hypoxia in tumor growth
    Cancer Cell 2004, 5: 221
    Proc Natl Acad Sci USA 2009, 106: 4260

     
  • In vivo imaging of tumor growth, metastasis and molecular pathways
    Am J Pathol 2006, 168: 2074
    Mol Cancer Therap 2007, 6: 1951
    Leukemia 2008, 22: 66
    Mol Imaging 2009, 8: 140
     
  • Development of targeted cancer therapies; Tumor hypoxia; In vivo imaging
    Role of p300 and CBP transcriptional co-activators in hematopoiesis, stem cell renewal, cell adhesion and tumor suppression (Genes Dev 14:272, 2000; Cell 102:839, 2000; Proc Natl Acad Sci USA 12;99:14789, 2002; Science 300: 342, 2003; Nat Struct Biol 10: 504, 2003)
    Role of hypoxia-inducible transcription in tumor growth (Nat Med 6:1335, 2000; Proc Natl Acad Sci USA 99:5367, 2002; Cancer Cell 6:33, 2004)
    In vivo imaging of tumor growth, metastasis and molecular pathways (Cancer Cell 3:173, 2003; Proc Natl Acad Sci USA 100:13513, 2003; Science 305:1466, 2004; Cancer Cell 9:473, 2006)
    Inhibition of insulin-like growth factor receptor-1 as a therapeutic strategy for cancer (Cancer Cell 5:221, 2004)
    Development of targeted cancer therapies (Cancer Cell 6:33, 2004)( Cancer Cell 5:221, 2004; Cancer Cell 7:129, 2005; Blood 107:1092, 2006)
     
  • Research site for Andrew Kung, MD, PhD

  •  Previous | Next  | Return to Search Results




    Andrew Li-Jen Kung, MD, PhD  
       

    Contact Information

    Primary Office Location
    Dana-Farber Cancer Institute
    Department of Pediatric Oncology
    44 Binney Street
    Boston, MA  02115
    View Map
    Driving Directions

    Phone: 617-632-5731
    Fax: 617-582-8096
    E-mail

    Other Office Location
    Children's Hospital Boston


    Contact Us Privacy Accessibility Give Now